0 Комментарии
0 Поделились
35 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Aarskog-Scott Syndrome Treatment Market Size, Share & Forecast 2033According to the latest report published by Data Bridge Market Research, the Aarskog-Scott Syndrome Treatment Market CAGR ValueData Bridge Market Research analyses that the global aarskog-scott syndrome treatment market which was USD 3.01 billion in 2022, is expected to reach USD 4.88 million by 2030, and is expected to undergo a CAGR of 6.20% during the forecast period of 2023 to...0 Комментарии 0 Поделились 4 Просмотры 0 предпросмотр
-
Autoimmune Polyglandular Syndrome Type 1 Market InsightsAutoimmune Polyglandular Syndrome Type 1 (APS-1) is a rare inherited autoimmune disorder characterized by the dysfunction of multiple endocrine glands, resulting in chronic health complications that require lifelong medical management. Growing awareness of rare autoimmune diseases, advancements in diagnostic technologies, and increasing investments in targeted therapies are contributing...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Leukodystrophy Drug Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Leukodystrophy Drug Market CAGR Value The global leukodystrophy drug market size was valued at USD 750.00 million in 2025 and is expected to reach USD 1,186.39 million by 2033, at a CAGR of 5.90% during the forecast period SWOT analysis and Porter’s Five Forces analysis are used to analyse...0 Комментарии 0 Поделились 721 Просмотры 0 предпросмотр